Study to Test the Accuracy of a Prototype Handheld PT/INR Device
|ClinicalTrials.gov Identifier: NCT01349712|
Recruitment Status : Unknown
Verified May 2011 by Universal Biosensors Pty Ltd.
Recruitment status was: Enrolling by invitation
First Posted : May 9, 2011
Last Update Posted : May 9, 2011
|Condition or disease|
|Blood Coagulation Disorders|
|Study Type :||Observational|
|Estimated Enrollment :||200 participants|
|Official Title:||Correlation of Feasibility Batches Using Warfarinised Blood|
|Study Start Date :||May 2011|
|Estimated Primary Completion Date :||November 2011|
|Estimated Study Completion Date :||November 2011|
Subjects are required to be currently receiving coumadin (warfarin) treatment.
- PT/INR values from the experimental device will be statistically correlated to results obtained from a commercially available device [ Time Frame: Fives days to collect data and up to two weeks to generate correlation graph ]To determine the correlation of PT/INR values between an experimental and commercial device.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01349712
|United States, Arkansas|
|White River Diagnostic Clinic|
|Batesville, Arkansas, United States, 72501|
|Principal Investigator:||Richard Ward, Pharm D||Harding University|